Technetium 99m isolation system and technetium 99m isolation method
AssigneeKyoto Medical Technology Co., Ltd
InventorNaruto Takahashi
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyoto Medical Technology Co., Ltd
InventorNaruto Takahashi
Estimating the term…
An initial introduction control part introduces an aqueous solution containing molybdenum 99 and technetium 99m, and an organic solvent being capable of dissolving the technetium 99m into an extraction tank. A micro-mixing control part micro-mixes the aqueous solution and the organic solvent by heating and stirring a mixed solution of the aqueous solution and the organic solvent introduced into the extraction tank with a heater, while applying ultrasonic to the mixed solution. A separation control part separates the mixed solution micro-mixed into two phases of aqueous solution and an organic solvent. A taking-out introduction control part passes the organic solvent separated into two phases through an adsorption column be capable of adsorbing molybdenum 99 and introduces the organic solvent into an evaporation elution tank. An evaporation control part evaporates the organic solvent and leaves residue by reducing pressure inside the evaporation elution tank and heating the organic solvent introduced into the evaporation elution tank with a heater, while applying ultrasonic to the organic solvent. An elution control part introduces physiological saline solution into the residue and elutes technetium 99m into the physiological saline solution from the residue.
A technetium 99m isolation system comprising:
A technetium 99m isolation method comprising:
Dependencies are inferred from the claim text.